| Compound | KissPeptin-10 |
|---|---|
| Category | Reproductive-axis research peptide |
| Class | Other Injectables |
| Evidence tier | Clinical-stage |
| WADA status | Not individually listed; verify current status if subject to testing |
| Sold on this site | No — this is a reference database |
Overview
This entry covers KissPeptin-10, a reproductive-axis research peptide, graded "Clinical-stage" in this catalog's evidence system. This compound has completed or is undergoing formal human trials. Human safety and efficacy are being characterized, but no universal approval exists and results may still fail or be withdrawn.
A peptide fragment of kisspeptin, the master upstream regulator of GnRH neurons, studied in human trials for reproductive endocrinology research.
Mechanism of Action
Kisspeptin activates GPR54 on GnRH neurons, driving the central control of puberty and fertility.
Research and Evidence
Clinical research programs (notably at Imperial College London/Hammersmith) have conducted human infusion studies in infertility contexts; no approved product yet.
Safety and Side Effects
Human research administration has been conducted under ethics protocols; routine clinical use is not established.
Frequently Asked Questions
What is the evidence tier of KissPeptin-10?
KissPeptin-10 is graded "Clinical-stage" on this site. This compound has completed or is undergoing formal human trials. Human safety and efficacy are being characterized, but no universal approval exists and results may still fail or be withdrawn.
Is KissPeptin-10 an approved medicine?
No. Clinical-stage means the compound has not reached universal regulatory approval; the tier description above explains exactly what level of evidence exists.
Where can I read the primary studies for KissPeptin-10?
The references section at the end of this entry links the key primary sources — regulator labels, trial registrations, and peer-reviewed papers. Our "How to Read a Peptide Study" guide explains how to evaluate them.
References
- ClinicalTrials.gov — registered kisspeptin studies. [source]
Evidence tier: Clinical-stage · Last reviewed: 2026-09-05 · Sources cited below.